NEW YORK (AVAFIN) -- Institutional trading of Mylan shares yielded a bought/sold volume ratio of 2.16.
A total of 25 block trades crossed the tape, resulting in 715,135
shares on the buy side vs. 331,755 shares on the sell side. From a cash flow perspective,
this implies that there was a cash inflow of $21,395,841 and a cash outflow of $9,877,257.
The net cash flow for MYL is $11,518,583, demonstrating that institutions may
have positive outlook on the stock.
On the options side, investors traded a total of 10,911 contracts.
Specifically, 6,660 call and 4,251 put contracts were traded yesterday yielding a 0.64
The trading volume of 12M is above the 90 day average volume of 5M shares.
Shares of Mylan edged up $1.04 (+3.64%) to $29.61. The price of the stock ranged
between a low of $29.34 and $30.47 respectively.
View Best Performing Stocks
Mylan, Inc. and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients.